My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 601

1.

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.

Breast Cancer Res. 2008;10(4):R69. Epub 2008 Aug 7.PMID: 18687126 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD.

Clin Cancer Res. 2002 May;8(5):1085-91.PMID: 12006523 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients]

Cai QQ, Huang HQ, Lin TX, Jiang WQ.

Ai Zheng. 2005 Jul;24(7):837-41. Chinese. PMID: 16004811 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ.

Clin Colorectal Cancer. 2006 Jul;6(2):125-32.PMID: 16945168 [PubMed - indexed for MEDLINE]Related articles

5.

Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.

Braun S, Hepp F, Kentenich CR, Janni W, Pantel K, Riethmüller G, Willgeroth F, Sommer HL.

Clin Cancer Res. 1999 Dec;5(12):3999-4004.PMID: 10632331 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.

Payne RE, Yagüe E, Slade MJ, Apostolopoulos C, Jiao LR, Ward B, Coombes RC, Stebbing J.

Pharmacogenomics. 2009 Jan;10(1):51-7.PMID: 19102715 [PubMed - indexed for MEDLINE]Related articles

7.

Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.

Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.

Anticancer Res. 2003 Mar-Apr;23(2C):1883-90.PMID: 12820473 [PubMed - indexed for MEDLINE]Related articles

8.

Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.

Bauernhofer T, Zenahlik S, Hofmann G, Balic M, Resel M, Pirchmoser R, Regitnig P, Ambros P, Dandachi N, Samonigg H.

Oncol Rep. 2005 Feb;13(2):179-84.PMID: 15643496 [PubMed - indexed for MEDLINE]Related articles

9.

Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.

Nunes RA, Li X, Kang SP, Burstein H, Roberts L, Carney W, Blackwell K, Ryan P, Borges V, Iglehart JD, Friedman P, Harris LN.

Int J Biol Markers. 2009 Jan-Mar;24(1):1-10.PMID: 19404916 [PubMed - indexed for MEDLINE]Related articles

10.

Molecular signature detection of circulating tumor cells using a panel of selected genes.

Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.

Cancer Lett. 2008 May 18;263(2):267-79. Epub 2008 Feb 8.PMID: 18262345 [PubMed - indexed for MEDLINE]Related articles

11.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

Br J Cancer. 2009 Aug 18;101(4):589-97. Epub 2009 Jul 21.PMID: 19623181 [PubMed - indexed for MEDLINE]Related articles

12.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(4):R46. Epub 2009 Jul 9.PMID: 19589136 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.

Lu J, Fan T, Zhao Q, Zeng W, Zaslavsky E, Chen JJ, Frohman MA, Golightly MG, Madajewicz S, Chen WT.

Int J Cancer. 2010 Feb 1;126(3):669-83.PMID: 19662651 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).

Kasimir-Bauer S, Oberhoff C, Schindler AE, Seeber S.

Int J Oncol. 2002 May;20(5):1027-34. Review.PMID: 11956600 [PubMed - indexed for MEDLINE]Related articles

15.

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K.

Clin Cancer Res. 2007 Feb 1;13(3):920-8.PMID: 17289886 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY.

Br J Cancer. 2010 Jan 19;102(2):276-84. Epub 2009 Dec 1.PMID: 19953098 [PubMed - indexed for MEDLINE]Related articles

17.

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.PMID: 18097410 [PubMed - indexed for MEDLINE]Related articles

18.

Enhanced Tumor Cell Isolation by a Biomimetic Combination of E-selectin and anti-EpCAM: Implications for the Effective Separation of Circulating Tumor Cells (CTCs).

Myung JH, Launiere CA, Eddington DT, Hong S.

Langmuir. 2010 Feb 16. [Epub ahead of print]PMID: 20155985 [PubMed - as supplied by publisher]Related articles

19.

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G, Lianidou E, Kakolyris S, Georgoulias V, Mavroudis D.

J Clin Oncol. 2009 May 1;27(13):2177-84. Epub 2009 Mar 30.PMID: 19332733 [PubMed - indexed for MEDLINE]Related articles

20.

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.

Pierga JY, Bonneton C, Vincent-Salomon A, de Cremoux P, Nos C, Blin N, Pouillart P, Thiery JP, Magdelénat H.

Clin Cancer Res. 2004 Feb 15;10(4):1392-400.PMID: 14977842 [PubMed - indexed for MEDLINE]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed
Write to the Help Desk